BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 34952266)

  • 1. Engineering therapeutic phages for enhanced antibacterial efficacy.
    Meile S; Du J; Dunne M; Kilcher S; Loessner MJ
    Curr Opin Virol; 2022 Feb; 52():182-191. PubMed ID: 34952266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phage-Derived Antibacterials: Harnessing the Simplicity, Plasticity, and Diversity of Phages.
    Kim BO; Kim ES; Yoo YJ; Bae HW; Chung IY; Cho YH
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30889807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriophage genome engineering for phage therapy to combat bacterial antimicrobial resistance as an alternative to antibiotics.
    Usman SS; Uba AI; Christina E
    Mol Biol Rep; 2023 Aug; 50(8):7055-7067. PubMed ID: 37392288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phages amid antimicrobial resistance.
    Mohan Raj JR; Karunasagar I
    Crit Rev Microbiol; 2019; 45(5-6):701-711. PubMed ID: 31775552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phage Therapy for Antibiotic-Resistant Bacterial Infections.
    Hatfull GF; Dedrick RM; Schooley RT
    Annu Rev Med; 2022 Jan; 73():197-211. PubMed ID: 34428079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future.
    Łobocka M; Dąbrowska K; Górski A
    BioDrugs; 2021 May; 35(3):255-280. PubMed ID: 33881767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a genetically modified T7Select phage system to express the antimicrobial peptide 1018.
    Lemon DJ; Kay MK; Titus JK; Ford AA; Chen W; Hamlin NJ; Hwang YY
    J Microbiol; 2019 Jun; 57(6):532-538. PubMed ID: 31054139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of bacteriophages against intracellular bacteria.
    Śliwka P; Ochocka M; Skaradzińska A
    Crit Rev Microbiol; 2022 Mar; 48(2):222-239. PubMed ID: 34428105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European regulatory aspects of phage therapy: magistral phage preparations.
    Verbeken G; Pirnay JP
    Curr Opin Virol; 2022 Feb; 52():24-29. PubMed ID: 34801778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phage Therapy: Going Temperate?
    Monteiro R; Pires DP; Costa AR; Azeredo J
    Trends Microbiol; 2019 Apr; 27(4):368-378. PubMed ID: 30466900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Making the leap from technique to treatment - genetic engineering is paving the way for more efficient phage therapy.
    Lewis JM; Williams J; Sagona AP
    Biochem Soc Trans; 2024 Jun; 52(3):1373-1384. PubMed ID: 38716972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combatting intracellular pathogens using bacteriophage delivery.
    Goswami A; Sharma PR; Agarwal R
    Crit Rev Microbiol; 2021 Aug; 47(4):461-478. PubMed ID: 33818246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Creation of synthetic bacterial viruses].
    Ando H
    Nihon Saikingaku Zasshi; 2018; 73(4):201-210. PubMed ID: 30487377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
    Luong T; Salabarria AC; Roach DR
    Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A commentary on the development of engineered phage as therapeutics.
    Barnard AML; Fairhead HIM
    Drug Discov Today; 2021 Sep; 26(9):2095-2098. PubMed ID: 34237459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
    Tagliaferri TL; Jansen M; Horz HP
    Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriophages: potential treatment for bacterial infections.
    Duckworth DH; Gulig PA
    BioDrugs; 2002; 16(1):57-62. PubMed ID: 11909002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Engineering and Biosynthesis Technology: Keys to Unlocking the Chains of Phage Therapy.
    Lv S; Wang Y; Jiang K; Guo X; Zhang J; Zhou F; Li Q; Jiang Y; Yang C; Teng T
    Viruses; 2023 Aug; 15(8):. PubMed ID: 37632078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fitness Trade-Offs Resulting from Bacteriophage Resistance Potentiate Synergistic Antibacterial Strategies.
    Mangalea MR; Duerkop BA
    Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32094257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Back to the future: bacteriophages as promising therapeutic tools.
    Domingo-Calap P; Georgel P; Bahram S
    HLA; 2016 Mar; 87(3):133-40. PubMed ID: 26891965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.